356 related articles for article (PubMed ID: 29632194)
1. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
[TBL] [Abstract][Full Text] [Related]
2. Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.
Ahn J; Kim KH; Park S; Ahn YH; Kim HY; Yoon H; Lee JH; Bang D; Lee DH
Oncotarget; 2016 Sep; 7(39):63252-63260. PubMed ID: 27533081
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
4. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.
Okayama H; Saito M; Oue N; Weiss JM; Stauffer J; Takenoshita S; Wiltrout RH; Hussain SP; Harris CC
Int J Cancer; 2013 Jan; 132(1):9-18. PubMed ID: 22618808
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.
Zha L; Cao Q; Cui X; Li F; Liang H; Xue B; Shi H
Med Oncol; 2016 Mar; 33(3):21. PubMed ID: 26819089
[TBL] [Abstract][Full Text] [Related]
6. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
[TBL] [Abstract][Full Text] [Related]
7. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
Weyandt JD; Carney JM; Pavlisko EN; Xu M; Counter CM
PLoS One; 2016; 11(12):e0167205. PubMed ID: 27911940
[TBL] [Abstract][Full Text] [Related]
8. DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6A.
Licht JD
Trans Am Clin Climatol Assoc; 2018; 129():24-36. PubMed ID: 30166694
[TBL] [Abstract][Full Text] [Related]
9. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
[TBL] [Abstract][Full Text] [Related]
10. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
11. In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor.
Hong H; Yao S; Zhang Y; Ye Y; Li C; Hu L; Sun Y; Huang HY; Ji H
PLoS Genet; 2020 Nov; 16(11):e1009168. PubMed ID: 33137086
[TBL] [Abstract][Full Text] [Related]
12.
Li F; Huang Q; Luster TA; Hu H; Zhang H; Ng WL; Khodadadi-Jamayran A; Wang W; Chen T; Deng J; Ranieri M; Fang Z; Pyon V; Dowling CM; Bagdatlioglu E; Almonte C; Labbe K; Silver H; Rabin AR; Jani K; Tsirigos A; Papagiannakopoulos T; Hammerman PS; Velcheti V; Freeman GJ; Qi J; Miller G; Wong KK
Cancer Discov; 2020 Feb; 10(2):270-287. PubMed ID: 31744829
[TBL] [Abstract][Full Text] [Related]
13. UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma.
Li X; Zhang Y; Zheng L; Liu M; Chen CD; Jiang H
Nat Commun; 2018 Jul; 9(1):2720. PubMed ID: 30006524
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
Schmidt ML; Hobbing KR; Donninger H; Clark GJ
Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
[TBL] [Abstract][Full Text] [Related]
15. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Yu T; Chen X; Zhang W; Liu J; Avdiushko R; Napier DL; Liu AX; Neltner JM; Wang C; Cohen D; Liu C
Cell Death Differ; 2016 Feb; 23(2):207-15. PubMed ID: 26113043
[TBL] [Abstract][Full Text] [Related]
16. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Kostyrko K; Román M; Lee AG; Simpson DR; Dinh PT; Leung SG; Marini KD; Kelly MR; Broyde J; Califano A; Jackson PK; Sweet-Cordero EA
Nat Commun; 2023 Jul; 14(1):3966. PubMed ID: 37407562
[TBL] [Abstract][Full Text] [Related]
17. [Distributions of H3K27me3 and its modification enzymes in different tissues of mice].
Wang Y; Wang X; Zhang R; Zhang Z; Wang Y; Yang B; Wang G; Zhang X; Ma F; Xu H; Wu X; Zhang F; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1491-1497. PubMed ID: 29268852
[TBL] [Abstract][Full Text] [Related]
18. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Mutant
Zhou X; Padanad MS; Evers BM; Smith B; Novaresi N; Suresh S; Richardson JA; Stein E; Zhu J; Hammer RE; O'Donnell KA
Mol Cancer Res; 2019 Feb; 17(2):594-603. PubMed ID: 30409919
[TBL] [Abstract][Full Text] [Related]
20. The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells.
Beyaz S; Kim JH; Pinello L; Xifaras ME; Hu Y; Huang J; Kerenyi MA; Das PP; Barnitz RA; Herault A; Dogum R; Haining WN; Yilmaz ÖH; Passegue E; Yuan GC; Orkin SH; Winau F
Nat Immunol; 2017 Feb; 18(2):184-195. PubMed ID: 27992400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
